These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3284630)

  • 1. Treatment of bulimia with desipramine: a double-blind crossover study.
    Barlow J; Blouin J; Blouin A; Perez E
    Can J Psychiatry; 1988 Mar; 33(2):129-33. PubMed ID: 3284630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bulimia: independence of antibulimic and antidepressant properties of desipramine.
    Blouin J; Blouin A; Perez E; Barlow J
    Can J Psychiatry; 1989 Feb; 34(1):24-9. PubMed ID: 2647270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bulimia with fenfluramine and desipramine.
    Blouin AG; Blouin JH; Perez EL; Bushnik T; Zuro C; Mulder E
    J Clin Psychopharmacol; 1988 Aug; 8(4):261-9. PubMed ID: 3062043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the drop-outs in psychopharmacological research with bulimics.
    Margittai KJ; Blouin A; Pérez E
    Int J Psychiatry Med; 1986-1987; 16(4):297-304. PubMed ID: 3549597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of antidepressant treatment for bulimia nervosa.
    Walsh BT; Hadigan CM; Devlin MJ; Gladis M; Roose SP
    Am J Psychiatry; 1991 Sep; 148(9):1206-12. PubMed ID: 1882999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study.
    McCann UD; Agras WS
    Am J Psychiatry; 1990 Nov; 147(11):1509-13. PubMed ID: 2221164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
    Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating bulimia with desipramine. A double-blind, placebo-controlled study.
    Hughes PL; Wells LA; Cunningham CJ; Ilstrup DM
    Arch Gen Psychiatry; 1986 Feb; 43(2):182-6. PubMed ID: 3511878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa.
    Agras WS; Rossiter EM; Arnow B; Telch CF; Raeburn SD; Bruce B; Koran LM
    J Clin Psychiatry; 1994 May; 55(5):179-83. PubMed ID: 8071266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa.
    Walsh BT; Hadigan CM; Wong LM
    J Clin Psychopharmacol; 1992 Jun; 12(3):163-8. PubMed ID: 1629381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2001; 2003(4):CD003391. PubMed ID: 11687198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Devos D; Dujardin K; Poirot I; Moreau C; Cottencin O; Thomas P; Destée A; Bordet R; Defebvre L
    Mov Disord; 2008 Apr; 23(6):850-7. PubMed ID: 18311826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
    Remick RA; Keller FD; Buchanan RA; Gibson RE; Fleming JA
    Can J Psychiatry; 1988 Oct; 33(7):590-4. PubMed ID: 3058290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in bulimia before and after successful treatment with desipramine.
    Hughes PL; Wells LA; Cunningham CJ
    J Clin Psychiatry; 1986 Oct; 47(10):515-7. PubMed ID: 3759916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication and psychotherapy in the treatment of bulimia nervosa.
    Walsh BT; Wilson GT; Loeb KL; Devlin MJ; Pike KM; Roose SP; Fleiss J; Waternaux C
    Am J Psychiatry; 1997 Apr; 154(4):523-31. PubMed ID: 9090340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
    Feingold A; Oliveto A; Schottenfeld R; Kosten TR
    Am J Addict; 2002; 11(2):111-23. PubMed ID: 12028741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desipramine relieves postherpetic neuralgia.
    Kishore-Kumar R; Max MB; Schafer SC; Gaughan AM; Smoller B; Gracely RH; Dubner R
    Clin Pharmacol Ther; 1990 Mar; 47(3):305-12. PubMed ID: 2178851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia.
    Mitchell JE; Christenson G; Jennings J; Huber M; Thomas B; Pomeroy C; Morley J
    J Clin Psychopharmacol; 1989 Apr; 9(2):94-7. PubMed ID: 2656781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison.
    Agras WS; Rossiter EM; Arnow B; Schneider JA; Telch CF; Raeburn SD; Bruce B; Perl M; Koran LM
    Am J Psychiatry; 1992 Jan; 149(1):82-7. PubMed ID: 1728190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.